PortfoliosLab logo

Alexion Pharmaceuticals, Inc.

ALXN
Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US0153511094
CUSIP
015351109

ALXNPrice Chart


Chart placeholderClick Calculate to get results
S&P 500

ALXNPerformance

The chart shows the growth of $10,000 invested in Alexion Pharmaceuticals, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $75,648 for a total return of roughly 656.48%. All prices are adjusted for splits and dividends.


ALXN (Alexion Pharmaceuticals, Inc.)
Benchmark (S&P 500)

ALXNReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M1.00%
6M14.99%
YTD16.81%
1Y66.61%
5Y7.48%
10Y11.98%

ALXNMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ALXNSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Alexion Pharmaceuticals, Inc. Sharpe ratio is 1.85. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


ALXN (Alexion Pharmaceuticals, Inc.)
Benchmark (S&P 500)

ALXNDividends


ALXN doesn't pay dividends

ALXNDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ALXN (Alexion Pharmaceuticals, Inc.)
Benchmark (S&P 500)

ALXNWorst Drawdowns

The table below shows the maximum drawdowns of the Alexion Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Alexion Pharmaceuticals, Inc. is 63.65%, recorded on Mar 16, 2020. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-63.65%Jul 24, 20151169Mar 16, 2020
-29.42%Oct 8, 201290Feb 19, 2013174Oct 25, 2013264
-24.08%Feb 28, 201431Apr 11, 2014135Oct 23, 2014166
-22.8%Dec 3, 2014106May 6, 201547Jul 14, 2015153
-18.53%Jul 25, 201111Aug 8, 201120Sep 6, 201131
-14.53%Apr 6, 201151Jun 17, 201119Jul 15, 201170
-14.24%Apr 21, 201025May 25, 201049Aug 4, 201074
-10.66%Mar 27, 201238May 18, 201221Jun 19, 201259
-9.39%Oct 25, 201136Dec 14, 20118Dec 27, 201144
-9.14%Sep 28, 20114Oct 3, 20115Oct 10, 20119

ALXNVolatility Chart

Current Alexion Pharmaceuticals, Inc. volatility is 21.88%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ALXN (Alexion Pharmaceuticals, Inc.)
Benchmark (S&P 500)

Portfolios with Alexion Pharmaceuticals, Inc.


Loading data...

More Tools for Alexion Pharmaceuticals, Inc.